Table 1 Clinical characteristics of 74 severe and critically ill patients
From: IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19
Clinical characteristics | Total (N = 74) | Severe patients, N (%) | Critically ill patients, N (%) | P |
|---|---|---|---|---|
Age [median(IQR),years] | 67 (57–72) | 60 (55–73) | 66 (59–71) | 0.176 |
Gender | ||||
Male | 45 (60.8%) | 8 (42.1%) | 37 (67.3%) | 0.024 |
Female | 29 (39.2%) | 11 (57.9%) | 18 (32.7%) | 0.053 |
Common symptoms | ||||
Fever | 63 (85.1%) | 16 (84.2%) | 47 (85.5%) | 0.895 |
Cough | 59 (79.7%) | 14 (73.7%) | 38 (69.1%) | 0.706 |
Dyspnoea | 46 (62.2%) | 11 (57.9%) | 36 (65.5%) | 0.555 |
Comorbidity | 62 (83.8%) | |||
Hypertension | 36 (48.6%) | 8 (42.1%) | 28 (50.9%) | 0.508 |
Diabetes | 14 (18.9%) | 5 (26.3%) | 9 (16.4%) | 0.34 |
Cardiovascular disease | 19 (25.7%) | 5 (26.3%) | 14 (25.5%) | 0.941 |